α,β-Methyleneadenosine 5'-triphosphate trisodium salt
Cat. No. 3209
Chemical Name: α,β-Methyleneadenosine 5'-triphosphate trisodium salt
Biological ActivityP2-purinoceptor agonist. Also shown to inhibit adenylate cyclase (Ki = 0.5 mM).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Burnstock and Kennedy (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen.Pharmacol 16 433. PMID: 2996968.
Krug et al (1973) α,β-Methylene-adenosine 5'-triphosphate. J.Biol.Chem. 248 1203. PMID: 4686923.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for α,β-Methyleneadenosine 5'-triphosphate trisodium salt include:
Haanes and Edvinsson (2014) Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine. PLoS One 9 e108782. PMID: 25265286.
Do you know of a great paper that uses α,β-Methyleneadenosine 5'-triphosphate trisodium salt from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: a,b-Methyleneadenosine 5'-triphosphate trisodium salt, supplier, P2, agonists, P2-purinoceptor, P2Y, Receptors, Purinergic, P2X, purinoceptors, α, β-Methyleneadenosines, alpha,beta-Methyleneadenosines, 5-triphosphate, trisodium, salt, a,b-Methyleneadenosine, Tocris Bioscience, Purinergic (P2Y) Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Potent FFA1 (GPR40) agonistCATPB
FFA2 antagonist/inverse agonistOleanolic acid
Selective GPBA receptor (TGR5) partial agonistPPTN hydrochloride
High affinity and selective P2Y14 antagonistItraconazole
SMO antagonist; acts at different binding site to cyclopamine (Cat No. 1623)SAR 216471 hydrochloride
Potent P2Y12 antagonist; orally availableA 971432
Potent and selective S1P5 agonistGLPG 0974
Potent FFA2 antagonistOgerin
Selective positive allosteric modulator at GPR68BGC 20-1531 hydrochloride
High affinity and selective EP4 antagonistMontelukast sodium
CysLT1 and GPR17 antagonist
October 30 - November 3, 2016
Boston, MA, USA